Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathryn P Gray

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
JAMA Network Open|June 16, 2025
Sudden Unexpected Infant Death Rates and Social Determinants of Health Among Hispanic InfantsBianca Quiñones-Pérez, Christopher Cortina, Anja Sandholm, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 18, 2017
Reply to L. MoscettiMarco Colleoni, Kathryn P Gray, Richard D Gelber, et al.
Prostate Cancer and Prostatic Diseases|September 5, 2020
Bone targeted therapy and skeletal related events in the era of enzalutamide and abiraterone acetate for castration resistant prostate cancer with bone metastasesBradley McGregor, Li Zhang, Kathryn P Gray, et al.
Academic Pediatrics|February 10, 2023
A Patient Portal Intervention to Promote Adolescent and Young Adult Self-Management SkillsSophie Allende-Richter, Ashley D Benitez, Melanie Ramirez, et al.
European Urology Oncology|August 15, 2019
Loss of PTEN Expression Detected by Fluorescence Immunohistochemistry Predicts Lethal Prostate Cancer in Men Treated with ProstatectomyAnis A Hamid, Kathryn P Gray, Ying Huang, et al.
AJR. American Journal of Roentgenology|September 24, 2014
Craniocaudal retroperitoneal node length as a risk factor for relapse from clinical stage I testicular germ cell tumorStephanie A Howard, Kathryn P Gray, Elizabeth K O'Donnell, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 10, 2012
Genetic variants in the host restriction factor APOBEC3G are associated with HIV-1-related disease progression and central nervous system impairment in childrenKumud K Singh, Yan Wang, Kathryn P Gray, et al.
The Prostate|October 18, 2013
Elevated insulin-like growth factor binding protein-1 (IGFBP-1) in men with metastatic prostate cancer starting androgen deprivation therapy (ADT) is associated with shorter time to castration resistance and overall survivalJaya Sharma, Kathryn P Gray, Carolyn Evan, et al.
Cancer|April 24, 2015
Docetaxel, bevacizumab, and androgen deprivation therapy for biochemical disease recurrence after definitive local therapy for prostate cancerRana R McKay, Kathryn P Gray, Julia H Hayes, et al.
The Journal of Urology|January 28, 2015
Patients with Biopsy Gleason 9 and 10 Prostate Cancer Have Significantly Worse Outcomes Compared to Patients with Gleason 8 DiseaseChe-Kai Tsao, Kathryn P Gray, Mari Nakabayashi, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
JAMA Network Open|June 16, 2025
Sudden Unexpected Infant Death Rates and Social Determinants of Health Among Hispanic InfantsBianca Quiñones-Pérez, Christopher Cortina, Anja Sandholm, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 18, 2017
Reply to L. MoscettiMarco Colleoni, Kathryn P Gray, Richard D Gelber, et al.
Prostate Cancer and Prostatic Diseases|September 5, 2020
Bone targeted therapy and skeletal related events in the era of enzalutamide and abiraterone acetate for castration resistant prostate cancer with bone metastasesBradley McGregor, Li Zhang, Kathryn P Gray, et al.
Academic Pediatrics|February 10, 2023
A Patient Portal Intervention to Promote Adolescent and Young Adult Self-Management SkillsSophie Allende-Richter, Ashley D Benitez, Melanie Ramirez, et al.
European Urology Oncology|August 15, 2019
Loss of PTEN Expression Detected by Fluorescence Immunohistochemistry Predicts Lethal Prostate Cancer in Men Treated with ProstatectomyAnis A Hamid, Kathryn P Gray, Ying Huang, et al.
AJR. American Journal of Roentgenology|September 24, 2014
Craniocaudal retroperitoneal node length as a risk factor for relapse from clinical stage I testicular germ cell tumorStephanie A Howard, Kathryn P Gray, Elizabeth K O'Donnell, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 10, 2012
Genetic variants in the host restriction factor APOBEC3G are associated with HIV-1-related disease progression and central nervous system impairment in childrenKumud K Singh, Yan Wang, Kathryn P Gray, et al.
The Prostate|October 18, 2013
Elevated insulin-like growth factor binding protein-1 (IGFBP-1) in men with metastatic prostate cancer starting androgen deprivation therapy (ADT) is associated with shorter time to castration resistance and overall survivalJaya Sharma, Kathryn P Gray, Carolyn Evan, et al.
Cancer|April 24, 2015
Docetaxel, bevacizumab, and androgen deprivation therapy for biochemical disease recurrence after definitive local therapy for prostate cancerRana R McKay, Kathryn P Gray, Julia H Hayes, et al.
The Journal of Urology|January 28, 2015
Patients with Biopsy Gleason 9 and 10 Prostate Cancer Have Significantly Worse Outcomes Compared to Patients with Gleason 8 DiseaseChe-Kai Tsao, Kathryn P Gray, Mari Nakabayashi, et al.
Pageof 6